Intravenous pamidronate treatment in osteogenesis imperfecta
- 1 October 1997
- journal article
- case report
- Published by Elsevier in The Journal of Pediatrics
- Vol. 131 (4), 622-625
- https://doi.org/10.1016/s0022-3476(97)70074-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal OsteoporosisNew England Journal of Medicine, 1995
- Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodelingThe American Journal of Medicine, 1995
- Osteopenia in cerebral palsy.Archives of Disease in Childhood, 1994
- Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfectaJournal of Bone and Mineral Research, 1994
- Bone mineral content and density in healthy subjects and in osteogenesis imperfecta.Archives of Disease in Childhood, 1994
- Aminohydroxypropylidene-biphosphonate in the treatment of bone lesions in a case of Gaucher's disease type 3Acta Paediatrica, 1994
- BisphosphonatesDrugs, 1991
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Increased Bone Turnover with Decreased Bone Formation by Osteoblasts in Children with Osteogenesis Imperfecta TardaPediatric Research, 1983
- DIPHOSPHONATES AND INHIBITION OF BONE MINERALISATIONThe Lancet, 1982